About Cognition Therapeutics

Developing small molecule therapies targeting Alzheimer’s disease and neuro- degenerative diseases.

Cognition Therapeutics Inc. is focused on the discovery and development of small molecule therapeutics targeting the toxic proteins that cause the cognitive decline associated with Alzheimer’s disease and other neuro- degenerative diseases of the human brain.

Contact Cognition Therapeutics

Phone Number
001-412-481-2210

More About Cognition Therapeutics

Therapeutic Areas
  • Central Nervous System
Technologies
  • Small molecules
Company Type
  • Biotechnology – Therapeutics
State of Ownership
  • Other